Skip to Main Content

Top of the morning to you. Another busy day is unfolding here on the Pharmalot campus, where we are mulling over our cluttered calendar and plotting our next moves. No doubt, you can relate. After all, this is only the middle of the week and there is so much to be done. This calls, as you may imagine, for a hot cup of stimulation. We are sticking with a favorite that has the aroma of Jack Daniel’s Tennessee Whiskey. Feel free to join us. Meanwhile, here are some tidbits. The world is a busy place, yes? Hope you make your way today …

Several former Insys Therapeutics (INSY) defendants derided “inflammatory” charges filed against them by the federal government in a filing that seeks to dismiss the case, according to this document filed in federal court in Boston. Prosecutors rely on “ugly insinuation about lawful business practices” used to promote the Subsys nasal spray, which contains the fentanyl painkiller. The former executives were accused of running a scheme that involved a sham speaker program and bribing doctors in order to boost prescriptions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!